MYBL2 and central nervous system cancer: Firstly, we transected GV230-MYBL2 (2 μg/mL) and pcDNA3.1 + HA-FOXM1 (2 μg/mL) to increase the genes expression in low grade glioma Hs683 cells, respectively.